{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:43:46Z","timestamp":1762508626590,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.eprac.2021.09.002","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T18:29:37Z","timestamp":1631125777000},"page":"90-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association Between Aldosterone and Parathyroid Hormone Levels in Patients With Adrenocortical Tumors"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3657-2070","authenticated-orcid":false,"given":"Guido","family":"Zavatta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Di Dalmazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Pelusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Golfieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mosconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Balacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio Roberto","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Di Cintio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Malandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uberto","family":"Pagotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Vicennati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eprac.2021.09.002_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0002-9343(85)90328-6","article-title":"Calcium metabolism and parathyroid function in primary aldosteronism","volume":"78","author":"Resnick","year":"1985","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.eprac.2021.09.002_bib2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/0895-7061(95)00182-O","article-title":"Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas","volume":"8","author":"Rossi","year":"1995","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.eprac.2021.09.002_bib3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/HJH.0b013e32834f0451","article-title":"Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism","volume":"30","author":"Maniero","year":"2012","journal-title":"J\u00a0Hypertens"},{"issue":"1","key":"10.1016\/j.eprac.2021.09.002_bib4","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1210\/jc.2011-2183","article-title":"Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study","volume":"97","author":"Pilz","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2021.09.002_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.eprac.2021.04.886","article-title":"Aldosterone secretion in patients with primary hyperparathyroidism without arterial hypertension","author":"Castellano","year":"2021","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.eprac.2021.09.002_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1210\/jc.2014-3949","article-title":"Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis","volume":"100","author":"Brown","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2021.09.002_bib7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jc.2013-3214","article-title":"A\u00a0high aldosterone to renin ratio is associated with high serum parathyroid hormone concentrations in the general population","volume":"99","author":"Fischer","year":"2014","journal-title":"J\u00a0Clin Endocrinol. Metab"},{"issue":"2","key":"10.1016\/j.eprac.2021.09.002_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/HYPERTENSIONAHA.112.195891","article-title":"Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma","volume":"60","author":"Rossi","year":"2012","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.eprac.2021.09.002_bib9","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00198-013-2399-1","article-title":"Bone health and aldosterone excess","volume":"24","author":"Ceccoli","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.eprac.2021.09.002_bib10","doi-asserted-by":"crossref","first-page":"836529","DOI":"10.1155\/2014\/836529","article-title":"Bone and mineral metabolism in patients with primary aldosteronism","volume":"2014","author":"Petramala","year":"2014","journal-title":"Int J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2021.09.002_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/HYPERTENSIONAHA.111.173948","article-title":"Primary hyperparathyroidism with concurrent primary aldosteronism","volume":"58","author":"Maniero","year":"2011","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.eprac.2021.09.002_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/HYPERTENSIONAHA.113.01910","article-title":"Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone","volume":"63","author":"Brown","year":"2014","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.eprac.2021.09.002_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ki.1972.107","article-title":"Renal handling of calcium and phosphate during mineralocorticoid \u201cescape\u201d in man","volume":"2","author":"Rastegar","year":"1972","journal-title":"Kidney Int"},{"issue":"1 Pt 1","key":"10.1016\/j.eprac.2021.09.002_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0895-7061(97)00366-X","article-title":"Acute effects of intravenous sodium chloride load on calcium metabolism and on parathyroid function in patients with primary aldosteronism compared with subjects with essential hypertension","volume":"11","author":"Rossi","year":"1998","journal-title":"Am J Hypertens"},{"issue":"6","key":"10.1016\/j.eprac.2021.09.002_bib15","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1210\/clinem\/dgaa123","article-title":"Disentangling the relationships between the renin-angiotensin-aldosterone system, calcium physiology, and risk for kidney stones","volume":"105","author":"Bayomy","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2021.09.002_bib16","first-page":"988","article-title":"Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems","volume":"75","author":"Grant","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2021.09.002_bib17","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1210\/jc.2012-1156","article-title":"Vitamin D3 therapy corrects the tissue sensitivity to angiotensin II akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study","volume":"97","author":"Vaidya","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2021.09.002_bib18","doi-asserted-by":"crossref","first-page":"e2119","DOI":"10.1002\/rmv.2119","article-title":"A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: implications for a potential treatment for COVID-19","volume":"30","author":"Mahdavi","year":"2020","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.eprac.2021.09.002_bib19","doi-asserted-by":"crossref","first-page":"105434","DOI":"10.1016\/j.jsbmb.2019.105434","article-title":"The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant \u201cneoplastic\u201d steroidogenesis in adrenals","volume":"193","author":"Gao","year":"2019","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"Pt B","key":"10.1016\/j.eprac.2021.09.002_bib20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jsbmb.2014.08.012","article-title":"Voltage-gated calcium channels in the human adrenal and primary aldosteronism","volume":"44","author":"Felizola","year":"2014","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"4","key":"10.1016\/j.eprac.2021.09.002_bib21","first-page":"E388","article-title":"Effects of calcium on renin and aldosterone in the rat","volume":"232","author":"Kotchen","year":"1977","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.eprac.2021.09.002_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000441-200507000-00001","article-title":"Bone loss in rats with aldosteronism","volume":"330","author":"Runyan","year":"2005","journal-title":"Am J Med Sci"},{"issue":"5","key":"10.1016\/j.eprac.2021.09.002_bib23","doi-asserted-by":"crossref","first-page":"H2023","DOI":"10.1152\/ajpheart.00477.2004","article-title":"Loss of bone minerals and strength in rats with aldosteronism","volume":"287","author":"Chhokar","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.eprac.2021.09.002_bib24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jacc.2005.03.055","article-title":"Diuretics and bone loss in rats with aldosteronism","volume":"46","author":"Law","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.eprac.2021.09.002_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrneph.2016.59","article-title":"Localization and function of the renal calcium-sensing receptor","volume":"12","author":"Riccardi","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.eprac.2021.09.002_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41574-020-0359-3","article-title":"Vitamin D supplementation: a novel therapy for aldosteronism?","volume":"16","author":"Rossi","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2021.09.002_bib27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/cen.14177","article-title":"The effect of vitamin D treatment on clinical and biochemical outcomes of primary aldosteronism","volume":"92","author":"Ismail","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.eprac.2021.09.002_bib28","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2021.09.002_bib29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-11-1039","article-title":"Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study","volume":"166","author":"Di Dalmazi","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2021.09.002_bib30","first-page":"103","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline","volume":"29","author":"Nieman","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2021.09.002_bib31","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"23","key":"10.1016\/j.eprac.2021.09.002_bib32","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function-measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.eprac.2021.09.002_bib33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jacc.2008.03.039","article-title":"Fracture risk in men with congestive heart failure risk reduction with spironolactone","volume":"52","author":"Carbone","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.eprac.2021.09.002_bib34","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jbmr.1660","article-title":"Bone involvement in aldosteronism","volume":"27","author":"Salcuni","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"issue":"2","key":"10.1016\/j.eprac.2021.09.002_bib35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/ijms19020455","article-title":"The impact of vitamin D in the treatment of essential hypertension","volume":"19","author":"Legarth","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.eprac.2021.09.002_bib36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ki.1982.168","article-title":"Importance of dietary sodium in the hypercalciuria syndrome","volume":"22","author":"Muldowney","year":"1982","journal-title":"Kidney Int"},{"key":"10.1016\/j.eprac.2021.09.002_bib37","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/jbmr.2536","article-title":"Serum 25-hydroxyvitamin D levels: variability, knowledge gaps, and the concept of a desirable range","volume":"30","author":"Fuleihan Gel-H","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"issue":"1","key":"10.1016\/j.eprac.2021.09.002_bib38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1210\/jcem-51-1-144","article-title":"Primary hyperparathyroidism: possible cause of primary hyperaldosteronism in a 60-year-old woman","volume":"51","author":"Barkan","year":"1980","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2021.09.002_bib39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ajh\/hpu102","article-title":"Secondary hypertension due to concomitant aldosterone-producing adenoma and parathyroid adenoma","volume":"28","author":"Chau","year":"2015","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.eprac.2021.09.002_bib40","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.1152\/ajpendo.2001.280.2.E209","article-title":"PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells","volume":"280","author":"Mazzocchi","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2021.09.002_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1152\/physiolgenomics.00187.2006","article-title":"Adrenal transcription regulatory genes modulated by angiotensin II and their role in steroidogenesis","volume":"30","author":"Romero","year":"2007","journal-title":"Physiol Genomics"},{"issue":"9","key":"10.1016\/j.eprac.2021.09.002_bib42","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1210\/jc.2019-00143","article-title":"PTH modulation by aldosterone and angiotensin II is blunted in hyperaldosteronism and rescued by adrenalectomy","volume":"104","author":"Lenzini","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2021.09.002_bib43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/jhh.2014.125","article-title":"The renin-angiotensin-aldosterone system and calcium-regulatory hormones","volume":"29","author":"Vaidya","year":"2015","journal-title":"Hum Hypertens"},{"issue":"7","key":"10.1016\/j.eprac.2021.09.002_bib44","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/HJH.0000000000000927","article-title":"Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial","volume":"34","author":"Tomaschitz","year":"2016","journal-title":"J.\u00a0Hypertens"},{"issue":"4","key":"10.1016\/j.eprac.2021.09.002_bib45","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/a-1027-6472","article-title":"Primary and secondary hyperparathyroidism in patients with primary aldosteronism - findings from the German Conn\u2019s Registry","volume":"128","author":"Asbach","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.eprac.2021.09.002_bib46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bone.2017.08.030","article-title":"Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism\u2014the randomized, placebo-controlled EPATH trial","volume":"105","author":"Verheyen","year":"2017","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.eprac.2021.09.002_bib47","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1464-5491.2007.02360.x","article-title":"Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels","volume":"25","author":"Sugden","year":"2008","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.eprac.2021.09.002_bib48","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.109.148619","article-title":"Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans","volume":"55","author":"Forman","year":"2010","journal-title":"Hypertension"},{"issue":"21","key":"10.1016\/j.eprac.2021.09.002_bib49","doi-asserted-by":"crossref","first-page":"35390","DOI":"10.18632\/oncotarget.15697","article-title":"Fine tuning of vitamin D receptor (VDR) activity by posttranscriptional and post-translational modifications","volume":"8","author":"Zenata","year":"2017","journal-title":"Oncotarget"},{"issue":"33","key":"10.1016\/j.eprac.2021.09.002_bib50","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.eprac.2021.09.002_bib51","doi-asserted-by":"crossref","first-page":"e82309","DOI":"10.1371\/journal.pone.0082309","article-title":"Vitamin D receptor, an important transcription factor associated with aldosterone-producing adenoma","volume":"8","author":"Changlong","year":"2013","journal-title":"PLoS One"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21012155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21012155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:12:14Z","timestamp":1761516734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X21012155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1530891X21012155"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2021.09.002","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Aldosterone and Parathyroid Hormone Levels in Patients With Adrenocortical Tumors","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2021.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}